Weiss Multi-Strategy Advisers’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-44,000	Closed	-$190K	–	758
2019 Q3	$190K	Hold	44,000	–	–	﹤0.01%	548
2019 Q2	$176K	Hold	44,000	–	–	﹤0.01%	472
2019 Q1	$236K	Sell	44,000 -23	-0.1%	-$149	0.01%	471
2018 Q4	$226K	Hold	44,023	–	–	0.01%	408
2018 Q3	$427K	Buy	44,023 +193	+0.4%	+$1.95K	0.01%	454
2018 Q2	$447K	Buy	43,830 +3,830	+10%	+$43.3K	0.01%	494
2018 Q1	$520K	Buy	40,000 +5,000	+14%	+$74.4K	0.02%	463
2017 Q4	$627K	Hold	35,000	–	–	0.02%	479
2017 Q3	$879K	Buy	35,000 +15,000	+75%	+$349K	0.03%	389
2017 Q2	$482K	Buy	20,000 +10,000	+100%	+$221K	0.02%	452
2017 Q1	$193K	Hold	10,000	–	–	0.01%	516
2016 Q4	$154K	Buy	+10,000	New	+$130K	0.01%	387
2016 Q2	–	Sell	-10,000	Closed	-$152K	–	521
2016 Q1	$152K	Hold	10,000	–	–	0.01%	433
2015 Q4	$190K	Sell	10,000 -5,000	-33%	-$95.4K	0.01%	348
2015 Q3	$285K	Buy	+15,000	New	+$374K	0.01%	356

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PRTK Position: Q4 2019 in Review

Weiss Multi-Strategy Advisers sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2019, closing a stake of 44,000 shares — an estimated $190K sold.

Weiss Multi-Strategy Advisers first reported a position in PRTK in Q3 2015 and held it in 15 quarters. The position peaked at $879K in Q3 2017. 93 funds tracked by Wall St. Rank hold PRTK as of Q4 2019.

Weiss Multi-Strategy Advisers reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 44,000 Paratek Pharmaceuticals, Inc. shares in Q4 2019, an estimated $190K.
Weiss Multi-Strategy Advisers first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2015 and held it in 15 quarters.
Weiss Multi-Strategy Advisers's Paratek Pharmaceuticals, Inc. position peaked at $879K in Q3 2017.
93 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.